Helena, MT, United States of America

Fred C Olson

This inventor holds 1 USPTO granted patent. Top assignee: Liposome Technology, Inc.. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fred C Olson - Innovator in Liposome Drug Delivery

Introduction

Fred C Olson is a notable inventor based in Helena, MT (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work with liposomes. His research focuses on enhancing the therapeutic effectiveness of cancer treatments.

Latest Patents

Fred C Olson holds 1 patent for a liposome drug delivery method and composition. This patent discloses a method for enhancing the therapeutic effectiveness of adriamycin in cancer treatment. The invention involves liposomes that contain coentrapped adriamycin and a secondary compound, which reduces the toxicity of adriamycin or enhances the tumoricidal activity of host lymphoid cells. These liposomes are administered parenterally in a therapeutically effective dose. Additionally, the patent describes the use of macrophages stimulated in vivo with liposomes containing entrapped liposomes, which are then exposed to an immunostimulator for enhanced tumoricidal activity.

Career Highlights

Fred C Olson is associated with Liposome Technology, Inc., where he continues to advance research in drug delivery systems. His work has the potential to significantly impact cancer treatment methodologies.

Collaborations

Fred has collaborated with notable colleagues, including Eric Mayhew and M Jane Ehrke, contributing to the advancement of liposome technology.

Conclusion

Fred C Olson's innovative work in liposome drug delivery represents a significant advancement in cancer treatment. His contributions continue to influence the field and offer hope for improved therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…